Skip to main content
SpringerLink
Log in

Differential Diagnosis of Severe Cutaneous Drug Eruptions

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Adverse cutaneous reactions to drugs are frequent, mostly secondary to antibacterials, however, serious adverse cutaneous reactions are infrequent. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are a spectrum of the same disease. They are the more severe drug eruptions, with a mortality around 30% for TEN. The confusion between erythema multiforme major and SJS means that erythema multiforme major is the main differential diagnosis. Skin disorders involving desquamation, in particular after pustulosis, are also common differential diagnoses. Mechanical or autoimmune blistering are also potential misdiagnoses of TEN/SJS.

Hypersensitivity Syndrome (HSS) or Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) is a severe cutaneous drug reaction with often a long duration of eruption and serious other organ involvement. Exfoliative dermatitis, whether caused by psoriasis, dermatitis or lymphoma, can be thought of as a differential diagnosis of DRESS/HSS. Angio-immunoblastic lymphadenopathy, viral eruption and vasculitis are other differential diagnoses of DRESS/HSS.

Prompt recognition of a severe drug reaction and withdrawal of the culprit drug is often the most important therapeutic action. Alternatively, a delay in starting a specific treatment for a disease misdiagnosed as a drug eruption could be deleterious.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Table II
Table III

Similar content being viewed by others

References

  1. Bigby M, Jick S, Jick H, et al. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15 438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358–63

    Article  PubMed  CAS  Google Scholar 

  2. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137: 765–70

    PubMed  CAS  Google Scholar 

  3. Hunziker T, Kunzi UP, Braunschweig S, et al. Comprehensive hospital drug monitoring: adverse skin reactions, a 20-year survey. Allergy 1997; 52: 388–93

    Article  PubMed  CAS  Google Scholar 

  4. Swanbeck G, Dahlberg E. Cutaneous drug reactions: an attempt to quantitative estimation. Arch Dermatol Res 1992; 284: 215–8

    Article  PubMed  CAS  Google Scholar 

  5. Ewards IR, Aronson JK. Adverse drug reaction: definition, diagnosis, and management. Lancet 2000; 356: 1255–9

    Article  Google Scholar 

  6. Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs: an analysis of spontaneous reports in four Italians regions. Br J Clin Pharmacol 1999; 48: 839–46

    Article  PubMed  CAS  Google Scholar 

  7. Roujeau JC, Stern RS. Severe cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272–85

    Article  PubMed  CAS  Google Scholar 

  8. Garcia-Doval I, LeCleach L, Bocquet H, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000; 136: 323–7

    Article  PubMed  CAS  Google Scholar 

  9. Bastuji-Garin S, Rzany B, Stern RS, et al. A clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993; 129: 92–6

    Article  PubMed  CAS  Google Scholar 

  10. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophtalmia: report of two cases in children. Am J Dis Child 1922; 24: 526–33

    Google Scholar 

  11. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956; 68: 355–61

    Article  PubMed  CAS  Google Scholar 

  12. Bastuji-Garin S, Zahedi M, Guillaume JC, et al. Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients. Age Ageing 1993; 22: 450–6

    Article  PubMed  CAS  Google Scholar 

  13. Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Erythema Multiforme Majus, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: correlations between clinical patterns and causes. Results of an international prospective study. Arch Dermatol 2002; 138: 1019–24

    Article  PubMed  Google Scholar 

  14. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600–7

    Article  PubMed  CAS  Google Scholar 

  15. Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, et al. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001; 28: 1843–8

    Article  Google Scholar 

  16. Rasmussen JE. Update to the Stevens-Johnson syndrome. Cleve Clin J Med 1988; 55: 412–4

    PubMed  CAS  Google Scholar 

  17. Roujeau JC, Guillaume JC, Febre JP, et al. Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France, 1981–1985. Arch Dermatol 1990; 126: 37–42

    Article  PubMed  CAS  Google Scholar 

  18. Schöpf E, Stühmer A, Rzany B, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 1991; 127 (6): 839–42

    Article  PubMed  Google Scholar 

  19. Fournier S, Bastuji-Garin S, Mentec H, et al. Toxic epidermal necrolysis associated with mycoplasma pneumoniae infection [letter]. Eur J Clin Microbiol Infect Dis 1995; 14: 558–9

    Article  PubMed  CAS  Google Scholar 

  20. Tay YK, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-John syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol 1996; 35: 757–60

    Article  PubMed  CAS  Google Scholar 

  21. de Groot R, Oranje AP, Vuzevski VD, et al. Toxic epidermal necrolysis probably due to Klebsiella pneumoniae sepsis. Dermatologica 1984; 169: 88–9

    Article  PubMed  Google Scholar 

  22. Picard E, Gillis D, Klapholz L, et al. Toxic epidermal necrolysis associated with Klebsiella pneumoniae sepsis. Pediatr Dermatol 1994; 11: 331–4

    Article  PubMed  CAS  Google Scholar 

  23. Bachot N, Roujeau JC. Physiopathology and treatment of severe drug eruptions. Curr Opin Allergy Clin Immunol 2001; 1: 293–8

    PubMed  CAS  Google Scholar 

  24. Becker DS. Toxic epidermal necrolysis. Lancet 1998; 351: 1417–20

    Article  PubMed  CAS  Google Scholar 

  25. Avakian R, Flowers FP, Araujo OE, et al. Toxic epidermal necrolysis: a review. J Am Acad Dermatol 1991; 25: 69–79

    Article  PubMed  CAS  Google Scholar 

  26. Revuz J. New advances in severe adverse drug reactions. Dermatol Clin 2001; 19: 697–709

    PubMed  CAS  Google Scholar 

  27. Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000; 115: 149–53

    Article  PubMed  CAS  Google Scholar 

  28. Prins C, Kerdel FA, Padilla RS, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139: 26–32

    Article  PubMed  CAS  Google Scholar 

  29. Trent JT, Kirsner RS, Romanelli P, et al. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol 2003; 139: 39–43

    Article  PubMed  CAS  Google Scholar 

  30. Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003; 139: 33–6

    Article  PubMed  CAS  Google Scholar 

  31. Assier H, Bastuji-Garin, S, et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131: 539–43

    Article  PubMed  CAS  Google Scholar 

  32. Leauté-Labreze C, Lamireay T, Chawki D, et al. Diagnosis, classification and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000; 83: 347–52

    Article  PubMed  Google Scholar 

  33. Machet L, Martin L, Vaillant L. Pustulose exanthématique aiguë généralisée. Ann Dermatol Venereol 2001; 128: 73–9

    PubMed  CAS  Google Scholar 

  34. Beylot C, Bioulac P, Doutre MS. Pustuloses exanthématiques aiguës généralisées. A propos de 4 cas. Ann Dermatol Venereol 1980; 107: 37–48

    PubMed  CAS  Google Scholar 

  35. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Arch Dermatol 1991; 127: 1333–8

    Article  PubMed  CAS  Google Scholar 

  36. Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP): a clinical reaction pattern. J Cutan Pathol 2001; 28: 113–9

    Article  PubMed  CAS  Google Scholar 

  37. Cohen AD, Cagnano E, Halevy S. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis. Int J Dermatol 2001; 40: 458–61

    Article  PubMed  CAS  Google Scholar 

  38. De Coninck AL, Van Strubarq AS, Pipeleers-Marichal MA, et al. Acute generalized exanthematous pustulosis induced by paracetamol: a case with severe hemodynamic disturbances. Dermatology 1996; 193: 338–41

    Article  PubMed  Google Scholar 

  39. Plano LR, Adkins B, Woischnik M, et al. Toxin levels in serum correlate with the development of staphylococcal scalded skin syndrome in a murine model. Infect Immun 2001; 69: 5193–7

    Article  PubMed  CAS  Google Scholar 

  40. Kuechle MK, Stegemeir E, Maynard B, et al. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol 1994; 30: 187–92

    Article  PubMed  CAS  Google Scholar 

  41. Nousari HC, Kimyai-Asadi A, Caeiro JP, et al. Clinical, demographic, and immunohistologic features of Vancomycin-Induced Linear Bullous Disease of the skin. Medicine 1999; 78: 1–8

    Article  PubMed  CAS  Google Scholar 

  42. Schneck B, Termeer C, Mockenhaupt M, et al. Linear IgA dermatosis in an adult with clinical signs of Stevens-Johnson syndrome. Hautarzt 1999; 50: 288–91

    Article  PubMed  CAS  Google Scholar 

  43. Kaur S, Thami GP, Mohan H, et al. Kikuchi disease with facial rash and erythema multiforme. Pediatr Dermatol 2001; 18: 403–5

    Article  PubMed  CAS  Google Scholar 

  44. Roustan G, Salas C, Barbadillo C, et al. Lupus erythematosus with an erythema multiforme-like eruption. Eur J Dermatol 2000; 10: 459–62

    PubMed  CAS  Google Scholar 

  45. Marzano AV, Berti E, Gasparini G, et al. Lupus erythematosus with antiphospholipid syndrome and erythema multiforme-like lesions. Br J Dermatol 1999; 141: 720–4

    Article  PubMed  CAS  Google Scholar 

  46. Robinson ND, Hashimoto T, Amagai M, et al. The new pemphigus variants. J Am Acad Dermatol 1999; 40: 649–71

    Article  PubMed  CAS  Google Scholar 

  47. Nguyen VT, Ndoye A, Bassler KD, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgane syndrome. Arch Dermatol 2001; 137: 193–206

    PubMed  CAS  Google Scholar 

  48. Speron S, Gamelli R. Toxic epidermal necrolysis syndrome versus mycosis fungoides. J Burn Care Rehabil 1997; 18: 421–3

    Article  PubMed  CAS  Google Scholar 

  49. Saltzstein S, Ackerman L. Lymphadenopathy induced by anticonvulsivant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer 1959; 12: 164–82

    Article  PubMed  CAS  Google Scholar 

  50. Shear N, Spielberg S. Anticonvulsivant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 1988; 82: 1826–32

    Article  PubMed  CAS  Google Scholar 

  51. Bocquet H, Bagot M, Roujeau JC. Drug induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinopholia and systemic symptoms-DRESS). Semin Cutan Med Surg 1996; 15: 250–7

    Article  PubMed  CAS  Google Scholar 

  52. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001; 137: 357–64

    PubMed  CAS  Google Scholar 

  53. Descamp V, Valence A, Edlinger C, et al. Association of human herpes virus 6 infection with drug reaction with eosiniphilia and systemic symptoms. Arch Dermatol 2001; 137: 301–4

    Google Scholar 

  54. Martel P, Laroche L, Courville P, et al. Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia. Arch Dermatol 2000; 136: 881–6

    Article  PubMed  CAS  Google Scholar 

  55. Sigurdsson V, Toonstra J, Hezemans-Boer M, et al. A clinical and follow-up study of 102 patients, with special emphasis on survival. J Am Acad Dermatol 1996; 35: 53–7

    Article  PubMed  CAS  Google Scholar 

  56. Asai T, Horiuchi Y. Senile erythroderma with serum hyper-IgE. Int J Dermatol 1989; 28: 225–8

    Article  Google Scholar 

  57. Abel EA. Diagnosis of drug-induced psoriasis. Semin Dermatol 1992; 11: 269–74

    PubMed  CAS  Google Scholar 

  58. Wilson NJ, Evans S. Severe pustular psoriasis provoked by oral terbinafine. Br J Dermatol 1998; 139: 168

    Article  PubMed  CAS  Google Scholar 

  59. Papa CA, Miller OF. Pustular psoriasiform eruption with leukocytosis associated with terbinafine. J Am Acad Dermatol 1998; 39: 115–7

    Article  PubMed  CAS  Google Scholar 

  60. Gupta AK, Lynde CW, Lauzon GJ, et al. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Br J Dermatol 1998; 138: 529–32

    Article  PubMed  CAS  Google Scholar 

  61. De Silva BD, Benton EC, Tidman MJ. Generalized pustular psoriasis following withdrawal of oral cyclosporin treatment for palmo-plantar pustulosis. Clin Exp Dermatol 1999; 24: 10–3

    Article  PubMed  Google Scholar 

  62. Davis MDP, Daoud MS, McEvoy MT, et al. Cutaneous mainfestations of Churg-Strauss syndrome: a clinicopathologic correlation. J Am Acad Dermatol 1997; 37: 199–203

    Article  PubMed  CAS  Google Scholar 

  63. Guillevin L, Le THD, Godeau P, et al. Clinical findings and prognosis of polyarteritis nodosa and Churg and Strauss angiitis: a study in 165 patients. Br J Rheumatol 1988; 27: 258–64

    Article  PubMed  CAS  Google Scholar 

  64. Pinching AJ, Lockwood CM, Pussel BA, et al. Wegener’s granulomatosis: observations on 18 patients with severe renal disease. Q J Med 1983; 208: 435–60

    Google Scholar 

  65. Cardinali C, Giomi B, Caproni M, et al. Maculopapular lupus rash in a young woman with systemic involvement. Lupus 2000; 9: 713–6

    Article  PubMed  CAS  Google Scholar 

  66. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125: 257–64

    PubMed  CAS  Google Scholar 

  67. Stoeckle MY. The spectrum of human herpesvirus 6 infection: from roseola infantum to adult disease. Annu Rev Med 2000; 51: 423–30

    Article  PubMed  CAS  Google Scholar 

  68. Renn CN, Straff W, Dorfmüller A, et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002; 147: 1166–70

    Article  PubMed  CAS  Google Scholar 

  69. Barbaud A, Goncalo M, Bruynzeel D, et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321–8

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors have provided no information on sources of funding or on conflicts of interest directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Dermatology, Hôpital Henri Mondor, Université Paris XII, 94010, Créteil, France

    Nicolas Bachot & Jean-Claude Roujeau

Authors
  1. Nicolas Bachot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Claude Roujeau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolas Bachot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bachot, N., Roujeau, JC. Differential Diagnosis of Severe Cutaneous Drug Eruptions. Am J Clin Dermatol 4, 561–572 (2003). https://doi.org/10.2165/00128071-200304080-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200304080-00006

Keywords

Search

Navigation